ArticlePediatric blood & cancer2025
Patient Characteristics and Neighborhood-Level Social Determinants of Health Associated With Childhood Cancer Survivor Follow-Up at Urban Cancer Centers.
Article in Pediatric blood & cancer, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
2 citing papers in PubMed.
- Article
- Cohort Profile: The Adolescent and Young Adult Tracking Engagement and Management Skills (AYA TEAMS) Longitudinal Cohort of Childhood Cancer Survivors in the United States.medRxiv : the preprint server for health sciences · 2026Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
13 authors.
Funding
Abstract
backgroundMany childhood cancer survivors (CCS) do not receive long-term follow-up care. We investigated the association of patient characteristics and neighborhood-level social determinants of health (SDOH) with follow-up.
methodsCCS (N = 354) diagnosed 2013-2022 at age <18 years were identified from cancer registries at two urban hospitals. Demographics and cancer history were abstracted from the cancer registries, supplemented by electronic health record data. Vital status was ascertained from the National Death Index. Neighborhood-level SDOH was measured with social vulnerability index, childhood opportunity index, and area deprivation index. Outcomes included survivorship clinic attendance ≥ 2 years posttherapy and any ambulatory visit ≥3 and ≥5 years posttherapy at the hospitals.
resultsSurvivorship clinic attendance was 52% ≥2 years posttherapy. Nonattendance was associated with adolescent age at diagnosis (42% for 11-17 vs. 65% for 6-10 years; p = 0.012), non-Hispanic Black race and ethnicity versus non-Hispanic White (32 vs. 57%, p = 0.048), and central nervous system (CNS) versus hematologic cancer (19 vs. 54%, p = 0.0005). The frequency of any ambulatory visit declined from 60% ≥3 years posttherapy to 40% ≥5 years posttherapy. Although 60% of CNS cancer survivors remained in ambulatory follow-up ≥5 years posttherapy, only 19% attended survivorship clinic. In multivariate analyses, neighborhood-level SDOH measures were not associated with follow-up.
conclusionsThere was a substantial drop in follow-up among CCS from 3 to 5 years posttherapy. Future studies of follow-up should focus on engagement of CNS cancer survivors, patients diagnosed during adolescence, and minority groups.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.